MedPath

Dose escalation study of intensity-modulated radiotherapy (IMRT) for ipsilateral intrathoracic recurrence after pneumonectomy (lung cancer/mediastinal tumor) or mesothelioma after extrapleural pneumonectomy

Phase 1
Conditions
Recurrence of thoracic malignancy (lung cancer/mediastinal tumor), or mesothelioma
Registration Number
JPRN-UMIN000004066
Lead Sponsor
Department of Radiation Oncology, Gunma University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
9
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patient with severe or uncontrolled systemic disease? 2) Patient with systemic active infection 3) Patient who is in pregnancy, lactating, or with a possibility of the pregnancy 4) Patient who is diagnosed with interstitial pneumonia or lung fibrosis by chest CT 5) Patient with severe heart disease (e.g. heart failure requiring medication, myocardial infarction/unstable angina pectoris within the past 3 months, uncontrolled arrhythmia) 6) Patient who is judged inappropriate for the entry into the study by the investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of adverse events, protocol compliance rate, to estimate the maximum tolerating dose (MTD) and to determine the recommended dose (RD)
Secondary Outcome Measures
NameTimeMethod
Median local control and estimation of chest pain
© Copyright 2025. All Rights Reserved by MedPath